bioRxiv · 10.1101/753152
Albumin inhibits the activation of hepatic stellate cells by suppressing TGF-β/Smad3 signaling via IL-1β
Abstract
Activated hepatic stellate cells (HSCs) play a key role in liver fibrosis and inactivating HSCs has been considered a promising therapeutic approach. We previously showed that albumin and its derivative, retinol binding protein (RBP)-albumin domain III fusion protein (named R-III), inhibit HSC activation. Here, we investigate the mode of action of albumin and R-III. NF-{kappa}B in activated HSCs was evenly distributed in the cytoplasm, but albumin expression and R-III treatment (albumin/R-III) induced NF-{kappa}B nuclear translocation via retinoic acid (RA) sequestration, resulting in increased expression of interleukin-1{beta} (IL-1{beta}). In an IL-1{beta} dependent manner, albumin/R-III inhibited Smad3 nuclear translocation via TAK1-, JNK-mediated Smad3 linker phosphorylation and decreased expression of Smad3 target genes, such as -smooth muscle actin and collagen type I. Mutation of the Smad3 linker phosphorylation sites abolished R-III effects on Smad3. In conclusion, our data suggest that the anti-fibrotic effects of albumin/R-III are due to RA sequestration which downregulates RAR-mediated signaling and also TGF-{beta}/Smad3 signaling. This mechanistic elucidation of albumin function in HSCs provides clues to understanding the frequent albumin mutations found in hepatocellular carcinoma.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Oh, J. S., Park, J. H., Kim, J., Choi, S.-Y., Cha, K., Park, H., Lee, J.-E., Lee, B., Moon, J. W., Park, S.-H., Lee, J. M., Lee, H.. 2019-08-31. Albumin inhibits the activation of hepatic stellate cells by suppressing TGF-β/Smad3 signaling via IL-1β. https://doi.org/10.1101/753152
Cite the original work for its findings. Save a collection to share your selection of sources.